Literature DB >> 28444406

[King's Parkinson's disease pain scale : Intercultural adaptation in the German language].

W H Jost1,2, A Rizos3, P Odin4,5, M Löhle6, A Storch6.   

Abstract

BACKGROUND: Pain is a frequent symptom of idiopathic Parkinson's disease and has a substantial impact on quality of life. The King's Parkinson's disease pain scale (KPPS) has become internationally established and is an English-language, standardized, reliable and valid scale for evaluation of pain in idiopathic Parkinson's disease. This article presents a validated version in German.
METHOD: The German translation was adapted interculturally and developed using an internationally recognized procedure in consultation with the authors of the original publication. The primary text was first translated by two bilingual neuroscientists independently of one another. Thereafter, the two versions were collated to generate a consensus version, which was accepted by the translators and preliminarily trialled with 10 patients. Hereafter, the German version was re-translated back into English by two other neurologists, again independently of one another, and a final consensus was agreed on using these versions. This English version was then compared with the original text by all of the translators, a process which entailed as many linguistic modifications to the German version as the translators considered necessary to generate a linguistically acceptable German version that was as similar as possible to the original English version. After this test text had been subsequently approved by the authors, the German text was applied to 50 patients in two hospitals, and reviewed as to its practicability and comprehensibility.
RESULTS: This work led to the successful creation of an inter-culturally adapted and linguistically validated German version of the KPPS. DISCUSSION: The German version presented here is a useful scare for recording and quantifying pain in empirical studies, as well as in clinical practice.

Entities:  

Keywords:  Pain; Pain scale; Parkinson’s disease; Translation; Validation

Mesh:

Year:  2018        PMID: 28444406     DOI: 10.1007/s00115-017-0333-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  20 in total

Review 1.  Emerging analgesic drugs for Parkinson's disease.

Authors:  Santiago Perez-Lloret; María Verónica Rey; Estelle Dellapina; Jean Pellaprat; Christine Brefel-Courbon; Olivier Rascol
Journal:  Expert Opin Emerg Drugs       Date:  2012-04-25       Impact factor: 4.191

Review 2.  Pain in Parkinson's disease.

Authors:  Blair Ford
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

3.  Parkinson's disease and pain--nondopaminergic mechanisms are likely to be important too.

Authors:  Shen-Yang Lim; Michael J Farrell; Andrew H Evans
Journal:  Mov Disord       Date:  2011-03-29       Impact factor: 10.338

Review 4.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

5.  Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials.

Authors:  Sandro Zambito-Marsala; Roberto Erro; Ruggero Bacchin; Annalisa Fornasier; Federico Fabris; Cecilia Lo Cascio; Franco Ferracci; Francesca Morgante; Michele Tinazzi
Journal:  Parkinsonism Relat Disord       Date:  2016-10-24       Impact factor: 4.891

Review 6.  The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Authors:  Klaus Seppi; Daniel Weintraub; Miguel Coelho; Santiago Perez-Lloret; Susan H Fox; Regina Katzenschlager; Eva-Maria Hametner; Werner Poewe; Olivier Rascol; Christopher G Goetz; Cristina Sampaio
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

7.  A survey of pain in idiopathic Parkinson's disease.

Authors:  Mark A Lee; Richard W Walker; Tony J Hildreth; Wendy M Prentice
Journal:  J Pain Symptom Manage       Date:  2006-11       Impact factor: 3.612

8.  The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

Authors:  Paolo Barone; Angelo Antonini; Carlo Colosimo; Roberto Marconi; Letterio Morgante; Tania P Avarello; Eugenio Bottacchi; Antonino Cannas; Gabriella Ceravolo; Roberto Ceravolo; Giulio Cicarelli; Roberto M Gaglio; Rosa M Giglia; Francesco Iemolo; Michela Manfredi; Giuseppe Meco; Alessandra Nicoletti; Massimo Pederzoli; Alfredo Petrone; Antonio Pisani; Francesco E Pontieri; Rocco Quatrale; Silvia Ramat; Rosanna Scala; Giuseppe Volpe; Salvatore Zappulla; Anna Rita Bentivoglio; Fabrizio Stocchi; Giorgio Trianni; Paolo Del Dotto
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

9.  Pain intensity on and off levodopa in patients with Parkinson's disease.

Authors:  Angelika Nebe; Georg Ebersbach
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

Review 10.  Pain management in patients with Parkinson's disease: challenges and solutions.

Authors:  Orjan Skogar; Johan Lokk
Journal:  J Multidiscip Healthc       Date:  2016-09-30
View more
  3 in total

1.  The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care.

Authors:  Odette Fründt; Tina Mainka; Beate Schönwald; Bianca Müller; Polina Dicusar; Christian Gerloff; Carsten Buhmann
Journal:  J Neural Transm (Vienna)       Date:  2018-08-22       Impact factor: 3.575

2.  Pain Assessment in Chinese Parkinson's Disease Patients Using King's Parkinson's Disease Pain Scale.

Authors:  Liang Gao; Weiling Huang; Laisheng Cai; Yufen Peng
Journal:  J Pain Res       Date:  2022-03-10       Impact factor: 3.133

3.  Non-motor symptoms burden in motor-fluctuating patients with Parkinson's disease may be alleviated by safinamide: the VALE-SAFI study.

Authors:  Claudia De Masi; Claudio Liguori; Matteo Spanetta; Mariana Fernandes; Rocco Cerroni; Elena Garasto; Mariangela Pierantozzi; Nicola Biagio Mercuri; Alessandro Stefani
Journal:  J Neural Transm (Vienna)       Date:  2022-09-07       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.